Jennifer Dasilva

Jennifer DaSilva is an experienced scientist with a strong background in molecular and cellular biology. Currently, Jennifer serves as a Scientist at Chroma Medicine and holds the position of Senior Associate Scientist II at Editas Medicine, where Jennifer has contributed to various significant projects since August 2019, including leading CRISPR-based screening efforts and small molecule identification in cancer research. Prior experience includes roles at Editas Medicine as Principal Screening Associate, Novartis Institutes for BioMedical Research as Scientist II, Millennium Pharmaceuticals as Sr Research Associate, and Dana-Farber Cancer Institute as Research Assistant. Jennifer's educational foundation is in Biochemistry and Molecular Biology from Boston University.